198 related articles for article (PubMed ID: 31352481)
1. The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.
Safreed-Harmon K; Blach S; Aleman S; Bollerup S; Cooke G; Dalgard O; Dillon JF; Dore GJ; Duberg AS; Grebely J; Boe Kielland K; Midgard H; Porter K; Razavi H; Tyndall M; Weis N; Lazarus JV
Clin Infect Dis; 2019 Nov; 69(12):2218-2227. PubMed ID: 31352481
[TBL] [Abstract][Full Text] [Related]
2. Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
Gamkrelidze I; Pawlotsky JM; Lazarus JV; Feld JJ; Zeuzem S; Bao Y; Gabriela Pires Dos Santos A; Sanchez Gonzalez Y; Razavi H
Liver Int; 2021 Mar; 41(3):456-463. PubMed ID: 33389788
[TBL] [Abstract][Full Text] [Related]
3. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
[TBL] [Abstract][Full Text] [Related]
4. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.
Moore MS; Bocour A; Laraque F; Winters A
Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392
[TBL] [Abstract][Full Text] [Related]
5. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
[TBL] [Abstract][Full Text] [Related]
6. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.
Eller AJ; DiDomizio EE; Madden LM; Oliva JD; Altice FL; Johnson KA
Ann Med; 2022 Dec; 54(1):1714-1724. PubMed ID: 35775786
[TBL] [Abstract][Full Text] [Related]
7. Mapping the hepatitis C cascade of care in people attending drug treatment services in England: A data linkage study.
Ireland G; Simmons R; Hickman M; Eastwood B; Ramsay M; Mandal S
Int J Drug Policy; 2019 Oct; 72():55-60. PubMed ID: 31257040
[TBL] [Abstract][Full Text] [Related]
8. Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil.
Bittencourt PL; Codes L; César AMDG; Mussi FC; Ferraz MLG
Telemed J E Health; 2023 Nov; 29(11):1673-1678. PubMed ID: 36888957
[No Abstract] [Full Text] [Related]
9. Design of an Enhanced Public Health Surveillance System for Hepatitis C Virus Elimination in King County, Washington.
Baer A; Fagalde MS; Drake CD; Sohlberg EH; Barash E; Glick S; Millman AJ; Duchin JS
Public Health Rep; 2020 Jan; 135(1):33-39. PubMed ID: 31835010
[TBL] [Abstract][Full Text] [Related]
10. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
[TBL] [Abstract][Full Text] [Related]
11. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
[TBL] [Abstract][Full Text] [Related]
13. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
14. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
[TBL] [Abstract][Full Text] [Related]
15. French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
Brouard C; Pillonel J; Boussac M; de Lédinghen V; Rachas A; Silvain C; Lydié N; Chevaliez S; Pioche C; Durand J; Lot F; Delarocque-Astagneau E
BMC Infect Dis; 2020 Oct; 20(1):759. PubMed ID: 33059617
[TBL] [Abstract][Full Text] [Related]
16. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
[TBL] [Abstract][Full Text] [Related]
17. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
van Santen DK; Sacks-Davis R; Doyle JS; Scott N; Prins M; Hellard M
J Viral Hepat; 2020 Aug; 27(8):770-773. PubMed ID: 32187431
[TBL] [Abstract][Full Text] [Related]
18. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Diagnosis and the Holy Grail.
Applegate TL; Fajardo E; Sacks JA
Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
[TBL] [Abstract][Full Text] [Related]
20. The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.
Chhatwal J; Chen Q; Bethea ED; Hur C; Spaulding AC; Kanwal F
Aliment Pharmacol Ther; 2019 Jul; 50(1):66-74. PubMed ID: 31115920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
